Harnessing the immune response to target tumors

por Manning, Luisa, Nemunaitis, John
Publicado 2017

Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics

por Vorhies, John S, Nemunaitis, John J
Publicado 2007

Emerging technologies for the genomic analysis of cancer

por Nemunaitis, John, Senzer, Neil N
Publicado 2009

Letter to the editor: Does Dicer Expression Affect shRNA processing?

por Senzer, Neil, Rao, Donald, Nemunaitis, John
Publicado 2009

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise

por Nemunaitis, John, Stanbery, Laura, Senzer, Neil
Publicado 2020

Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease

por Simmons, Olivia, Maples, Phillip B., Senzer, Neil, Nemunaitis, John
Publicado 2012

Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer

por Nemunaitis, John, Stanbery, Laura, Walter, Adam, Rocconi, Rodney, Stephens, Philip
Publicado 2023

Phase 1 dose escalation of ONT-10, a therapeutic MUC1 vaccine, in patients with advanced cancer

por Nemunaitis, John, Bedell, Cynthia, Klucher, Kevin, Vo, Alex, Whiting, Sam
Publicado 2013

Ovarian Cancer Immunotherapy and Personalized Medicine

por Morand, Susan, Devanaboyina, Monika, Staats, Hannah, Stanbery, Laura, Nemunaitis, John
Publicado 2021

BRCA1/2 Mutation Status Impact on Autophagy and Immune Response: Unheralded Target

por Morand, Susan, Stanbery, Laura, Walter, Adam, Rocconi, Rodney P, Nemunaitis, John
Publicado 2020

Systemic benefit of radiation therapy via abscopal effect

por Craig, Daniel J., Ambrose, Stephanie, Stanbery, Laura, Walter, Adam, Nemunaitis, John
Publicado 2022

Hereditary Inclusion Body Myopathy (HIBM2)

por Jay, Chris M., Levonyak, Nick, Nemunaitis, Gregory, Maples, Phillip B., Nemunaitis, John
Publicado 2009

HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case report

por Fortman, Dylan, Issa, Rochell, Stanbery, Laura, Albrethsen, Mary, Nemunaitis, John, Kasunic, Timothy
Publicado 2019

FDA efficiency for approval process of COVID-19 therapeutics

por Cassidy, Christine, Dever, Danielle, Stanbery, Laura, Edelman, Gerald, Dworkin, Lance, Nemunaitis, John
Publicado 2020

A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer

por Cohen, Roger B, Nemunaitis, John, Gabrail, Nashat, Bazhenova, Lyudmila, Schreiber, Taylor H, Price, Melissa
Publicado 2014

Procoagulant inhibitory properties of paclitaxel poliglumex

por Nemunaitis, John, Senzer, Neil, Cooper, Barry, Nemunaitis, Michael, Bedell, Cynthia, Singer, Jack W, Oldham, Fred B
Publicado 2010

Adenomatous polyposis coli in cancer and therapeutic implications

por Noe, Olivia, Filipiak, Louis, Royfman, Rachel, Campbell, Austin, Lin, Leslie, Hamouda, Danae, Stanbery, Laura, Nemunaitis, John
Publicado 2021

Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer

por Barve, Minal, Aaron, Phylicia, Manning, Luisa, Bognar, Ernest, Wallraven, Gladice, Horvath, Staci, Stanbery, Laura, Nemunaitis, John
Publicado 2022

Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy

por Alqahtani, Ali, Choucair, Khalil, Ashraf, Mushtaq, Hammouda, Danae M, Alloghbi, Abduraham, Khan, Talal, Senzer, Neil, Nemunaitis, John
Publicado 2019

Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma

por Sobol, Robert E., Menander, Kerstin B., Chada, Sunil, Wiederhold, Dora, Sellman, Beatha, Talbott, Max, Nemunaitis, John J.
Publicado 2021